NDC 0574-0293 – hydromorphone hydrochloride

Hydromorphone Hydrochloride 8 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug DEA schedule CII

Product NDC0574-0293

Product details

Brand name
hydromorphone hydrochloride
Generic name
hydromorphone hydrochloride
Labeler
Padagis US LLC
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA204278
Marketed since
May 22, 2015
Listing expires
December 31, 2027
Pharmacologic class
Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Hydromorphone Hydrochloride →

Package NDC codes (1)

Package NDCDescriptionSince
0574-0293-01100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0293-01)May 22, 2015

Other Hydromorphone Hydrochloride products